Try our Advanced Search for more refined results

In Re Allergan PLC Securities Litigation

  1. February 20, 2024

    2nd Circ. Won't Restore Allergan Investors' Breast Implant Suit

    A Second Circuit panel on Tuesday declined to revive a class action accusing Allergan Ltd. of downplaying cancer risks linked to the company's breast implants, holding in a summary order that the investors failed to show any duty by Allergan to disclose certain information related to the alleged health concerns, or that the company made any false or misleading statements.

  2. February 07, 2024

    2nd Circ. Skeptical Of Reviving Investors' Breast Implant Suit

    The Second Circuit on Wednesday wondered whether there was enough evidence to revive a class action lawsuit accusing Allergan Ltd. of downplaying cancer risks linked to the company's breast implants, with the judges questioning investor claims that public statements addressing the concerns left out necessary information. 

  3. July 27, 2023

    Allergan Asks 2nd Circ. To End Investors' Breast Implant Suit

    Allergan Ltd. has urged the Second Circuit to uphold the dismissal of a class action alleging that the pharmaceutical company did not disclose a strong link between its breast implants and a rare form of cancer, or alternatively, to vacate the class certification.

  4. December 12, 2022

    Allergan Snags Win In Investor Class Action Over Implants

    A New York federal judge handed a win to Allergan PLC on Monday, ruling that a class of investors hasn't plausibly alleged that the company failed to disclose a "serious and known link" between the company's breast implants and a rare form of cancer.

  5. September 09, 2021

    Allergan Investor Class Certified With New Lead Plaintiff

    A group of investors in pharmaceutical company Allergan PLC received class certification from a New York federal judge Wednesday for their allegations that the company failed to properly disclose a "serious and known link" between the company's breast implants and a rare form of cancer.

  6. January 22, 2021

    New Lead Plaintiff Seeks Cert. In Allergan Investor Action

    Investors in pharmaceutical company Allergan PLC urged a New York federal judge Thursday to grant class certification in their suit alleging the company failed to properly disclose a "serious and known link" between the company's breast implants and a rare form of cancer.

  7. December 09, 2020

    Faruqi & Faruqi Replaces Pomerantz In Allergan Suit

    Faruqi & Faruqi will represent a proposed class of investors in the pharmaceutical company Allergan after Pomerantz lost its lead counsel status in the consolidated securities litigation, a Manhattan federal judge said Monday.

  8. September 29, 2020

    Allergan Investors Lose Class Cert. Bid Over 'Serial Litigant'

    Allergan investors lost a bid to pursue a stock-drop suit as a class action against the pharmaceutical company, with a New York federal judge ruling Tuesday that the proposed lead plaintiff, which Allergan derided as a "serial litigant," isn't fit to represent the proposed class.

  9. July 29, 2020

    Allergan Says Proposed Class Rep Is 'Serial Litigant'

    Pharmaceutical company Allergan on Tuesday told a New York federal judge not to certify a proposed class of its investors in a stock drop suit it faces, calling the lead plaintiff a "serial litigant" and contending that the trimmed suit didn't show the company's alleged misstatements moved the needle of the company's stock price.

  10. February 03, 2020

    Allergan Investors Seek Class Cert. In Implant Stock Drop Suit

    Investors in pharmaceutical company Allergan are seeking certification for a shareholder class in their action, which alleges the company downplayed the connection between the company's breast implants and a form of cancer.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!